ORBIVAC
The major outstanding challenges of orbi-virus vaccine research is to develop vaccines that can afford a broad protective immune response against as many serotypes of each virus as possible, and to develop a high throughput DIVA assay (e.g. an ELISA). This project will use a coordinated multi-partner approach to address these issues, to develop new experimental prototype vaccines and diagnostic approaches.